{"disease":{"id":"dry-eye-disease","name":"Dry eye disease","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":3},"drugs":{"marketed":[{"drug_id":"perfluorohexyloctane","indication_name":"Dry Eye Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Miebo","generic_name":"PERFLUOROHEXYLOCTANE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"","drug_class":"Semifluorinated Alkane [EPC]","quality_score":44,"revenue":null,"mechanism":"Miebo works by mimicking the natural oils in the eyes to help maintain moisture."},{"drug_id":"chembl-chembl160","indication_name":"Dry Eye Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CYCLOSPORINE","company_name":"","drug_phase":"marketed","molecular_target":"calcineurin","drug_class":"Calcineurin Inhibitor Immunosuppressant [EPC]","quality_score":35,"revenue":null,"mechanism":"Cyclosporine, a calcineurin inhibitor, selectively modulates the immune system."},{"drug_id":"perfluorohexyloctane","indication_name":"Dry eye disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Miebo","generic_name":"PERFLUOROHEXYLOCTANE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"","drug_class":"Semifluorinated Alkane [EPC]","quality_score":44,"revenue":null,"mechanism":"Miebo works by mimicking the natural oils in the eyes to help maintain moisture."},{"drug_id":"acoltremon","indication_name":"dry eye disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tryptyr","generic_name":"ACOLTREMON","company_name":"Alcon Labs Inc","drug_phase":"marketed","molecular_target":"","drug_class":"TRPM8 Thermoreceptor Agonist [EPC]","quality_score":41,"revenue":null,"mechanism":"Tryptyr works by modulating the function of the lacrimal gland to increase tear production."},{"drug_id":"acoltremon","indication_name":"dry eye disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tryptyr","generic_name":"ACOLTREMON","company_name":"Alcon Labs Inc","drug_phase":"marketed","molecular_target":"","drug_class":"TRPM8 Thermoreceptor Agonist [EPC]","quality_score":41,"revenue":null,"mechanism":"Tryptyr works by modulating the function of the lacrimal gland to increase tear production."},{"drug_id":"miebo","indication_name":"Dry eye disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Miebo","company_name":"Bausch & Lomb Incorporated","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06605495","title":"Using Dry Eye As a Disease Model, Investigators Demonstrated the Optimal Selection of Individualized Clinical Interventions and the Superiority of Dynamic Treatment Discrimination in Chinese Medicine.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Xuejing Lu","has_results":false},{"nct_id":"NCT07457021","title":"A Study to Evaluate the Safety and Effectiveness of Perfluorohexyloctane Eye Drops on Treatment of Dry Eye Disease (DED) Related to Meibomian Gland Dysfunction (MGD)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Xiamen Ophthalmology Center Affiliated to Xiamen University","has_results":false},{"nct_id":"NCT06018571","title":"Burden of Illness and Treatment Assessment of Patients With Dry Eye Disease: A Cross-Sectional Survey of Real-World Patients With Dry Eye Disease in the US","phase":"","overall_status":"COMPLETED","enrollment_count":946,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04523129","title":"ESSENCE 2: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":834,"lead_sponsor_name":"Novaliq GmbH","has_results":true},{"nct_id":"NCT06879782","title":"Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":820,"lead_sponsor_name":"Lunan Better Pharmaceutical Co., LTD.","has_results":false},{"nct_id":"NCT04036292","title":"Evaluation of the Efficacy and Safety of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":758,"lead_sponsor_name":"Oyster Point Pharma, Inc.","has_results":true},{"nct_id":"NCT04735393","title":"A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":757,"lead_sponsor_name":"Aldeyra Therapeutics, Inc.","has_results":true},{"nct_id":"NCT05695781","title":"Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":740,"lead_sponsor_name":"BRIM Biotechnology Inc.","has_results":false},{"nct_id":"NCT01743729","title":"A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":720,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT02284516","title":"A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":711,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT05403827","title":"A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":644,"lead_sponsor_name":"Kowa Research Institute, Inc.","has_results":true},{"nct_id":"NCT05848128","title":"Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":642,"lead_sponsor_name":"Mimetogen Pharmaceuticals USA, Inc.","has_results":false},{"nct_id":"NCT03652415","title":"DRy Eye Outcome and Prescription Study","phase":"","overall_status":"UNKNOWN","enrollment_count":635,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT04567329","title":"Effect of NOV03 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Mojave Study)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":620,"lead_sponsor_name":"Bausch & Lomb Incorporated","has_results":true},{"nct_id":"NCT04658238","title":"Ocular Microbiome and Immune System in Dry Eyes","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT04139798","title":"Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":599,"lead_sponsor_name":"Bausch & Lomb Incorporated","has_results":true},{"nct_id":"NCT01421498","title":"Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":588,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT07524725","title":"Effect of Behavioral Intervention (Baduanjin Alone or Laughter Exercise Plus Artificial Tears) Versus Artificial Tear on Dry Eye Disease: a Randomised Controlled Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":540,"lead_sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","has_results":false},{"nct_id":"NCT05360966","title":"Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":467,"lead_sponsor_name":"Aerie Pharmaceuticals","has_results":true},{"nct_id":"NCT05285644","title":"Study Evaluating the Safety and Efficacy of AR-15512","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":465,"lead_sponsor_name":"Aerie Pharmaceuticals","has_results":true},{"nct_id":"NCT07020871","title":"Correlation of Dry Eye Disease, Problematic Smartphone Use and Sleep Quality in Adolescents and Young Adults","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":453,"lead_sponsor_name":"Wei XIA, PhD","has_results":false},{"nct_id":"NCT05653921","title":"Prospective Study to Validate the Imaging Biomarker for NCP (R33)","phase":"","overall_status":"SUSPENDED","enrollment_count":438,"lead_sponsor_name":"Tufts Medical Center","has_results":false},{"nct_id":"NCT06424444","title":"A Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":421,"lead_sponsor_name":"Aldeyra Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04393441","title":"Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT06942793","title":"A Study to Evaluate the Efficacy and Safety of Treatment With CsA-PG Ophthalmic Gel in Dry Eye Patients","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":396,"lead_sponsor_name":"Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.","has_results":false},{"nct_id":"NCT04498182","title":"A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":369,"lead_sponsor_name":"Aerie Pharmaceuticals","has_results":true},{"nct_id":"NCT07025811","title":"A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":350,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT04144413","title":"3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":350,"lead_sponsor_name":"Santen SAS","has_results":true},{"nct_id":"NCT04734197","title":"A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":349,"lead_sponsor_name":"Surface Ophthalmics, Inc.","has_results":true},{"nct_id":"NCT05378945","title":"Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":340,"lead_sponsor_name":"Corxel Pharmaceuticals","has_results":false},{"nct_id":"NCT03333057","title":"Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":336,"lead_sponsor_name":"Novaliq GmbH","has_results":true},{"nct_id":"NCT01636206","title":"Safety Study of Lifitegrast to Treat Dry Eye","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":332,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT03108664","title":"HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":330,"lead_sponsor_name":"Sylentis, S.A.","has_results":false},{"nct_id":"NCT05743764","title":"HU007 in Patients with Dry Eye Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":328,"lead_sponsor_name":"Huons Co., Ltd.","has_results":false},{"nct_id":"NCT03292809","title":"CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":328,"lead_sponsor_name":"Novaliq GmbH","has_results":true},{"nct_id":"NCT06244316","title":"A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":317,"lead_sponsor_name":"Dompé Farmaceutici S.p.A","has_results":true},{"nct_id":"NCT05515471","title":"Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":312,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT05310422","title":"Safety Study of Tivanisiran to Treat Dry Eye","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":301,"lead_sponsor_name":"Sylentis, S.A.","has_results":false},{"nct_id":"NCT06023108","title":"Assess the Effects of Spectacles or Orthokeratology on Dry Eye Parameters in Children and Adolescents.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"He Eye Hospital","has_results":false},{"nct_id":"NCT03956225","title":"Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":299,"lead_sponsor_name":"Alcon Research","has_results":true},{"nct_id":"NCT04421300","title":"A Randomized Study of Smile Exercise for Dry Eye","phase":"NA","overall_status":"COMPLETED","enrollment_count":299,"lead_sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","has_results":false},{"nct_id":"NCT04030962","title":"A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":292,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT04548427","title":"Study to Evaluate the Efficacy and Safety of CKD-352","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":283,"lead_sponsor_name":"Chong Kun Dang Pharmaceutical","has_results":false},{"nct_id":"NCT05493111","title":"A Long-Term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":275,"lead_sponsor_name":"Aerie Pharmaceuticals","has_results":true},{"nct_id":"NCT07243275","title":"SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT06696625","title":"Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye","phase":"NA","overall_status":"RECRUITING","enrollment_count":256,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT04140227","title":"Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"Bausch & Lomb Incorporated","has_results":true},{"nct_id":"NCT05797896","title":"Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Complement Therapeutics","has_results":false},{"nct_id":"NCT05759208","title":"The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Okyo Pharma Ltd","has_results":false},{"nct_id":"NCT04084483","title":"A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":238,"lead_sponsor_name":"Kowa Research Institute, Inc.","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}